{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T02:09:12Z","timestamp":1780106952784,"version":"3.54.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["954798"],"award-info":[{"award-number":["954798"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ando.2026.102520","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T16:17:28Z","timestamp":1774023448000},"page":"102520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic mechanisms of primary aldosteronism"],"prefix":"10.1016","volume":"87","author":[{"given":"May","family":"Fayad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolo\u2019","family":"Faedda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheerazed","family":"Boulkroun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Christina","family":"Zennaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio L.","family":"Fernandes-Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10258","key":"10.1016\/j.ando.2026.102520_bib0590","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.ando.2026.102520_bib0595","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ando.2026.102520_bib0600","doi-asserted-by":"crossref","first-page":"683","DOI":"10.7326\/L20-1097","article-title":"The unrecognized prevalence of primary aldosteronism","volume":"173","author":"Vaidya","year":"2020","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.ando.2026.102520_bib0605","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/clinem\/dgaf284","article-title":"Primary aldosteronism: an endocrine society clinical practice guideline","volume":"110","author":"Adler","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ando.2026.102520_bib0610","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/HYPERTENSIONAHA.111.175083","article-title":"Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms)","volume":"58","author":"Mulatero","year":"2011","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.ando.2026.102520_bib0615","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ando.2026.102520_bib0620","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"10.1016\/j.ando.2026.102520_bib0625","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.CIR.95.6.1471","article-title":"Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma","volume":"95","author":"Rossi","year":"1997","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ando.2026.102520_bib0630","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/CIRCIMAGING.112.974576","article-title":"Demonstration of blood pressure-independent noninfarct myocardial fibrosis in primary aldosteronism: a cardiac magnetic resonance imaging study","volume":"5","author":"Freel","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.ando.2026.102520_bib0635","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.kint.2022.12.021","article-title":"New advances in endocrine hypertension: from genes to biomarkers","volume":"103","author":"Fernandes-Rosa","year":"2023","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.ando.2026.102520_bib0640","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/s41588-023-01498-5","article-title":"Somatic SLC30A1 mutations altering zinc transporter ZnT1 cause aldosterone-producing adenomas and primary aldosteronism","volume":"55","author":"Rege","year":"2023","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.ando.2026.102520_bib0645","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1161\/HYPERTENSIONAHA.125.24909","article-title":"Somatic mutations in MCOLN3 are associated with aldosterone-producing adenomas","volume":"82","author":"van Rooyen","year":"2025","journal-title":"Hypertension"},{"key":"10.1016\/j.ando.2026.102520_bib0650","doi-asserted-by":"crossref","first-page":"19546","DOI":"10.1038\/srep19546","article-title":"Activating mutations in CTNNB1 in aldosterone producing adenomas","volume":"6","author":"\u00c5kerstr\u00f6m","year":"2016","journal-title":"Sci Rep"},{"issue":"15","key":"10.1016\/j.ando.2026.102520_bib0655","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJMoa1504869","article-title":"Pregnancy, primary aldosteronism, and adrenal CTNNB1 mutations","volume":"373","author":"Teo","year":"2015","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ando.2026.102520_bib0660","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41588-021-00906-y","article-title":"Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause","volume":"53","author":"Zhou","year":"2021","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.ando.2026.102520_bib0665","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s41588-023-01403-0","article-title":"Somatic mutations of CADM1 in aldosterone-producing adenomas and gap junction-dependent regulation of aldosterone production","volume":"55","author":"Wu","year":"2023","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.ando.2026.102520_bib0670","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1038\/s41467-022-32896-8","article-title":"Identification of risk loci for primary aldosteronism in genome-wide association studies","volume":"13","author":"Le Floch","year":"2022","journal-title":"Nat Commun"},{"issue":"14","key":"10.1016\/j.ando.2026.102520_bib0675","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/CIRCULATIONAHA.122.062349","article-title":"Genetic risk of primary aldosteronism and its contribution to hypertension: a cross-ancestry meta-analysis of genome-wide association studies","volume":"147","author":"Naito","year":"2023","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.ando.2026.102520_bib0680","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.034180","article-title":"Primary aldosteronism and risk of cardiovascular outcomes: genome-wide association and mendelian randomization study","volume":"13","author":"Inoue","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.ando.2026.102520_bib0685","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1152\/physrev.00030.2003","article-title":"Control of aldosterone secretion: a model for convergence in cellular signaling pathways","volume":"84","author":"Sp\u00e4t","year":"2004","journal-title":"Physiol Rev"},{"issue":"4","key":"10.1016\/j.ando.2026.102520_bib0690","doi-asserted-by":"crossref","first-page":"H989","DOI":"10.1152\/ajpheart.00073.2018","article-title":"New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease: translational and sex-specific effects","volume":"315","author":"Davel","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ando.2026.102520_bib0695","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0083-6729(03)01002-1","article-title":"Aldosterone: its receptor, target genes, and actions","volume":"66","author":"Pearce","year":"2003","journal-title":"Vitam Horm"},{"issue":"8","key":"10.1016\/j.ando.2026.102520_bib0700","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00424-022-02732-5","article-title":"Regulation of distal tubule sodium transport: mechanisms and roles in homeostasis and pathophysiology","volume":"474","author":"Pearce","year":"2022","journal-title":"Pflugers Arch"},{"issue":"1","key":"10.1016\/j.ando.2026.102520_bib0705","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.ando.2026.102520_bib0710","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mce.2011.07.034","article-title":"Acute and chronic regulation of aldosterone production","volume":"350","author":"Hattangady","year":"2012","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"10.1016\/j.ando.2026.102520_bib0715","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1055\/s-0029-1243601","article-title":"TASK1 and TASK3 potassium channels: determinants of aldosterone secretion and adrenocortical zonation","volume":"42","author":"Bandulik","year":"2010","journal-title":"Horm Metab Res"},{"issue":"6357","key":"10.1016\/j.ando.2026.102520_bib0720","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.ando.2026.102520_bib0725","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1073\/pnas.89.17.8327","article-title":"Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2","volume":"89","author":"Pascoe","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.ando.2026.102520_bib0730","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-0031-1299730","article-title":"The prevalence of familial hyperaldosteronism in apparently sporadic primary aldosteronism in Germany: a single center experience","volume":"44","author":"Pallauf","year":"2012","journal-title":"Horm Metab Res"},{"issue":"6","key":"10.1016\/j.ando.2026.102520_bib0735","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1161\/HYPERTENSIONAHA.110.168740","article-title":"Frequency of familial hyperaldosteronism type 1 in a hypertensive pediatric population: clinical and biochemical presentation","volume":"57","author":"Aglony","year":"2011","journal-title":"Hypertension"},{"issue":"22","key":"10.1016\/j.ando.2026.102520_bib0740","first-page":"1109","article-title":"Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone","volume":"95","author":"Sutherland","year":"1966","journal-title":"Can Med Assoc J"},{"issue":"2","key":"10.1016\/j.ando.2026.102520_bib0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecl.2011.01.012","article-title":"Glucocorticoid-remediable aldosteronism","volume":"40","author":"Halperin","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"9","key":"10.1016\/j.ando.2026.102520_bib0750","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2005-0681","article-title":"Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I","volume":"90","author":"Stowasser","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"1 Pt 2","key":"10.1016\/j.ando.2026.102520_bib0755","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/01.HYP.31.1.445","article-title":"Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism","volume":"31","author":"Litchfield","year":"1998","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.ando.2026.102520_bib0760","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jcem.85.9.6834","article-title":"Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension","volume":"85","author":"Stowasser","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"6018","key":"10.1016\/j.ando.2026.102520_bib0765","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.ando.2026.102520_bib0770","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1210\/en.2012-1241","article-title":"The potassium channel, Kir3.4 participates in angiotensin II-stimulated aldosterone production by a human adrenocortical cell line","volume":"153","author":"Oki","year":"2012","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.ando.2026.102520_bib0775","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1210\/en.2011-1733","article-title":"Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis","volume":"153","author":"Oki","year":"2012","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.ando.2026.102520_bib0780","doi-asserted-by":"crossref","first-page":"E155","DOI":"10.1210\/jc.2014-3009","article-title":"Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance","volume":"100","author":"Cheng","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ando.2026.102520_bib0785","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1113\/JP282690","article-title":"A revised mechanism of action of hyperaldosteronism-linked mutations in cytosolic domains of GIRK4 (KCNJ5)","volume":"600","author":"Shalomov","year":"2022","journal-title":"J Physiol"},{"issue":"2","key":"10.1016\/j.ando.2026.102520_bib0790","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/HYPERTENSIONAHA.114.03419","article-title":"Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma","volume":"64","author":"Fernandes-Rosa","year":"2014","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.ando.2026.102520_bib0795","doi-asserted-by":"crossref","first-page":"E1089","DOI":"10.1210\/jc.2015-2149","article-title":"A meta-analysis of somatic KCNJ5 K(+) channel mutations in 1636 patients with an aldosterone-producing adenoma","volume":"100","author":"Lenzini","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ando.2026.102520_bib0800","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1210\/jc.2011-2885","article-title":"Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas","volume":"97","author":"Taguchi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ando.2026.102520_bib0805","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/HYPERTENSIONAHA.114.03346","article-title":"Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma","volume":"65","author":"Zheng","year":"2015","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.ando.2026.102520_bib0810","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/cen.12873","article-title":"Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype","volume":"83","author":"Scholl","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.ando.2026.102520_bib0815","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/HYPERTENSIONAHA.111.186478","article-title":"Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism","volume":"59","author":"Boulkroun","year":"2012","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.ando.2026.102520_bib0820","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/HYPERTENSIONAHA.118.12064","article-title":"18-oxocortisol synthesis in aldosterone-producing adrenocortical adenoma and significance of KCNJ5 mutation status","volume":"73","author":"Tezuka","year":"2019","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ando.2026.102520_bib0825","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/HYPERTENSIONAHA.115.06186","article-title":"Genotype-specific steroid profiles associated with aldosterone-producing adenomas","volume":"67","author":"Williams","year":"2016","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.ando.2026.102520_bib0830","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/HYPERTENSIONAHA.119.14177","article-title":"Genetic, cellular, and molecular heterogeneity in adrenals with aldosterone-producing adenoma","volume":"75","author":"De Sousa","year":"2020","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.ando.2026.102520_bib0835","doi-asserted-by":"crossref","first-page":"E819","DOI":"10.1210\/jc.2011-2965","article-title":"Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors","volume":"97","author":"Azizan","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"10.1016\/j.ando.2026.102520_bib0840","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.mce.2013.01.018","article-title":"KCNJ5 mutations in aldosterone producing adenoma and relationship with adrenal cortex remodeling","volume":"371","author":"Boulkroun","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ando.2026.102520_bib0845","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.mce.2015.01.020","article-title":"Functional histopathological markers of aldosterone producing adenoma and somatic KCNJ5 mutations","volume":"408","author":"Fernandes-Rosa","year":"2015","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"10.1016\/j.ando.2026.102520_bib0850","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1161\/HYPERTENSIONAHA.119.13476","article-title":"Primary aldosteronism: KCNJ5 mutations and adrenocortical cell growth","volume":"74","author":"Yang","year":"2019","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.ando.2026.102520_bib0855","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1210\/jc.2008-0594","article-title":"A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism","volume":"93","author":"Geller","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ando.2026.102520_bib0860","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/HYPERTENSIONAHA.111.183996","article-title":"KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism","volume":"59","author":"Mulatero","year":"2012","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.ando.2026.102520_bib0865","doi-asserted-by":"crossref","first-page":"E1861","DOI":"10.1210\/jc.2013-2428","article-title":"a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III","volume":"98","author":"Monticone","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ando.2026.102520_bib0870","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nrendo.2012.230","article-title":"Role of KCNJ5 in familial and sporadic primary aldosteronism","volume":"9","author":"Mulatero","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.ando.2026.102520_bib0875","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000358197","article-title":"Discordant genotype- phenotype correlation in familial hyperaldosteronism type III with KCNJ5 gene mutation: a patient report and review of the literature","volume":"82","author":"Adachi","year":"2014","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.ando.2026.102520_bib0880","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.mce.2016.10.025","article-title":"Disordered zonal and cellular CYP11B2 enzyme expression in familial hyperaldosteronism type","volume":"439","author":"Gomez-Sanchez","year":"2017","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"10.1016\/j.ando.2026.102520_bib0885","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.neulet.2010.08.085","article-title":"Signaling complexes of voltage-gated sodium and calcium channels","volume":"486","author":"Catterall","year":"2010","journal-title":"Neurosci Lett"},{"issue":"9","key":"10.1016\/j.ando.2026.102520_bib0890","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ng.2716","article-title":"Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension","volume":"45","author":"Azizan","year":"2013","journal-title":"Nat Gen"},{"issue":"9","key":"10.1016\/j.ando.2026.102520_bib0895","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/ng.2695","article-title":"Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism","volume":"45","author":"Scholl","year":"2013","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.ando.2026.102520_bib0900","doi-asserted-by":"crossref","first-page":"49","DOI":"10.17116\/jnevro201811812149","article-title":"The third case report a patient with primary aldosteronism, seizures, and neurologic abnormalities (PASNA) syndrome de novo variant mutations in the CACNA1D gene","volume":"118","author":"Semenova","year":"2018","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"issue":"1","key":"10.1016\/j.ando.2026.102520_bib0905","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/19336950.2020.1761171","article-title":"A de novo CACNA1D missense mutation in a patient with congenital hyperinsulinism, primary hyperaldosteronism and hypotonia","volume":"14","author":"De Mingo Alemany","year":"2020","journal-title":"Channels (Austin)"},{"issue":"10","key":"10.1016\/j.ando.2026.102520_bib0910","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2018-01004","article-title":"Targeted molecular characterization of aldosterone-producing adenomas in White Americans","volume":"103","author":"Nanba","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ando.2026.102520_bib0915","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.118.12070","article-title":"Genetic characteristics of aldosterone-producing adenomas in Blacks","volume":"73","author":"Nanba","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.ando.2026.102520_bib0920","doi-asserted-by":"crossref","first-page":"e06315","DOI":"10.7554\/eLife.06315","article-title":"Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism","volume":"4","author":"Scholl","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.ando.2026.102520_bib0925","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ebiom.2016.10.002","article-title":"CACNA1H mutations are associated with different forms of primary aldosteronism","volume":"13","author":"Daniil","year":"2016","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.ando.2026.102520_bib0930","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1161\/HYPERTENSIONAHA.119.14349","article-title":"Somatic CACNA1H mutation as a cause of aldosterone-producing adenoma","volume":"75","author":"Nanba","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ando.2026.102520_bib0935","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1146\/annurev.biochem.71.102201.141218","article-title":"Biochemistry of Na,K-ATPase","volume":"71","author":"Kaplan","year":"2002","journal-title":"Annu Rev Biochem"},{"issue":"4","key":"10.1016\/j.ando.2026.102520_bib0940","doi-asserted-by":"crossref","DOI":"10.1038\/ng.2550","article-title":"Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension","volume":"45","author":"Beuschlein","year":"2013","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.ando.2026.102520_bib0945","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1210\/en.2015-1466","article-title":"Pathogenesis of adrenal aldosterone-producing adenomas carrying mutations of the Na(+)\/K(+)-ATPase","volume":"156","author":"Stindl","year":"2015","journal-title":"Endocrinology"},{"issue":"20","key":"10.1016\/j.ando.2026.102520_bib0950","doi-asserted-by":"crossref","first-page":"10981","DOI":"10.3390\/ijms222010981","article-title":"ATP1A1 mutant in aldosterone-producing adenoma leads to cell proliferation","volume":"22","author":"Kobuke","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.ando.2026.102520_bib0955","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1530\/ERC-15-0321","article-title":"Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas","volume":"22","author":"Akerstrom","year":"2015","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"10.1016\/j.ando.2026.102520_bib0960","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1210\/en.2015-2029","article-title":"Cellular pathophysiology of an adrenal adenoma-associated mutant of the plasma membrane Ca(2+)- ATPase ATP2B3","volume":"157","author":"Tauber","year":"2016","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.ando.2026.102520_bib0965","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1152\/physrev.00047.2017","article-title":"CLC chloride channels and transporters: structure, function, physiology, and disease","volume":"98","author":"Jentsch","year":"2018","journal-title":"Physiol Rev"},{"issue":"3","key":"10.1016\/j.ando.2026.102520_bib0970","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41588-018-0048-5","article-title":"CLCN2 chloride channel mutations in familial hyperaldosteronism type II","volume":"50","author":"Scholl","year":"2018","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.ando.2026.102520_bib0975","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41588-018-0053-8","article-title":"A gain-of- function mutation in the CLCN2 chloride channel gene causes primary aldosteronism","volume":"50","author":"Fernandes-Rosa","year":"2018","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.ando.2026.102520_bib0980","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1038\/s41467-019-13033-4","article-title":"Elevated aldosterone and blood pressure in a mouse model of familial hyperaldosteronism with ClC-2 mutation","volume":"10","author":"Schewe","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ando.2026.102520_bib0985","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1038\/s41467-019-12113-9","article-title":"Pathogenesis of hypertension in a mouse model for human CLCN2 related hyperaldosteronism","volume":"10","author":"G\u00f6ppner","year":"2019","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.ando.2026.102520_bib0990","doi-asserted-by":"crossref","first-page":"K37","DOI":"10.1530\/EJE-19-0377","article-title":"A somatic mutation in CLCN2 identified in a sporadic aldosterone-producing adenoma","volume":"181","author":"Dutta","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.ando.2026.102520_bib0995","doi-asserted-by":"crossref","first-page":"bvaa123","DOI":"10.1210\/jendso\/bvaa123","article-title":"Identification of somatic mutations in CLCN2 in aldosterone-producing adenomas","volume":"4","author":"Rege","year":"2020","journal-title":"J Endocr Soc"},{"issue":"9","key":"10.1016\/j.ando.2026.102520_bib1000","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3390\/biomedicines9091167","article-title":"Novel mutations detection with next-generation sequencing and its association with clinical outcome in unilateral primary aldosteronism","volume":"9","author":"Wu","year":"2021","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.ando.2026.102520_bib1005","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/hmg\/ddt484","article-title":"WNT\/\u03b2-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production","volume":"23","author":"Berthon","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.ando.2026.102520_bib1010","doi-asserted-by":"crossref","first-page":"107524","DOI":"10.1016\/j.celrep.2020.107524","article-title":"Beta-catenin causes adrenal hyperplasia by blocking zonal transdifferentiation","volume":"31","author":"Pignatti","year":"2020","journal-title":"Cell Rep"},{"issue":"1\u20132","key":"10.1016\/j.ando.2026.102520_bib1015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.mce.2010.11.014","article-title":"The Wnt\/beta-catenin pathway in adrenocortical development and cancer","volume":"332","author":"El Wakil","year":"2011","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"10.1016\/j.ando.2026.102520_bib1020","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1365-2265.2007.03033.x","article-title":"Frequent mutations of beta-catenin gene in sporadic secreting adrenocortical adenomas","volume":"68","author":"Tadjine","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2\u20133","key":"10.1016\/j.ando.2026.102520_bib1025","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.mam.2012.05.008","article-title":"The SLC30 family of zinc transporters\u00a0\u2013\u00a0a review of current understanding of their biological and pathophysiological roles","volume":"34","author":"Huang","year":"2013","journal-title":"Mol Aspects Med"},{"issue":"4","key":"10.1016\/j.ando.2026.102520_bib1030","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/HYPERTENSIONAHA.118.11086","article-title":"Cellular and genetic causes of idiopathic hyperaldosteronism","volume":"72","author":"Omata","year":"2018","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.ando.2026.102520_bib1035","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.ando.2026.102520_bib1040","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/EJE-21-0338","article-title":"Somatic mutations in adrenals from patients with primary aldosteronism not cured after adrenalectomy suggest common pathogenic mechanisms between unilateral and bilateral disease","volume":"185","author":"Hacini","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.ando.2026.102520_bib1045","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/HYPERTENSIONAHA.111.186205","article-title":"Mutations of the potassium channel KCNJ5 causing aldosterone-producing adenomas: one or two hits?","volume":"59","author":"Gomez-Sanchez","year":"2012","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.ando.2026.102520_bib1050","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1210\/er.2017-00189","article-title":"Genetic causes of functional adrenocortical adenomas","volume":"38","author":"Zennaro","year":"2017","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.ando.2026.102520_bib1055","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1210\/clinem\/dgaa484","article-title":"International histopathology consensus for unilateral primary aldosteronism","volume":"106","author":"Williams","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ando.2026.102520_bib1060","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1210\/jc.2009-2010","article-title":"Adrenocortical zonation in humans under normal and pathological conditions","volume":"95","author":"Nishimoto","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ando.2026.102520_bib1065","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.110.158543","article-title":"Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism","volume":"56","author":"Boulkroun","year":"2010","journal-title":"Hypertension"},{"issue":"33","key":"10.1016\/j.ando.2026.102520_bib1070","doi-asserted-by":"crossref","first-page":"E4591","DOI":"10.1073\/pnas.1505529112","article-title":"Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands","volume":"112","author":"Nishimoto","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ando.2026.102520_bib1075","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.mce.2016.10.014","article-title":"Immunohistochemistry of aldosterone synthase leads the way to the pathogenesis of primary aldosteronism","volume":"441","author":"Nishimoto","year":"2017","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.ando.2026.102520_bib1080","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1210\/jc.2015-3285","article-title":"Case report: nodule development from subcapsular aldosterone-producing cell clusters causes hyperaldosteronism","volume":"101","author":"Nishimoto","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2026.102520_bib1085","doi-asserted-by":"crossref","first-page":"e05410","DOI":"10.1002\/advs.202505410","article-title":"Integrated transcriptomics reveals evolutionary trajectories and cell density-dependent mechanisms in aldosterone-producing adenomas","author":"Sun","year":"2026","journal-title":"Adv Sci (Weinh)"},{"issue":"12","key":"10.1016\/j.ando.2026.102520_bib1090","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1210\/en.2011-1205","article-title":"Aldosterone-producing adenoma formation in the adrenal cortex involves expression of stem\/progenitor cell markers","volume":"152","author":"Boulkroun","year":"2011","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.ando.2026.102520_bib1095","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1210\/jc.2015-3239","article-title":"Molecular heterogeneity in aldosterone-producing adenomas","volume":"101","author":"Nanba","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ando.2026.102520_bib1100","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1210\/jc.2016-1874","article-title":"Aldosterone-producing adenoma with a somatic KCNJ5 mutation revealing APC-dependent familial adenomatous polyposis","volume":"101","author":"Vouillarmet","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ando.2026.102520_bib1105","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1210\/clinem\/dgab707","article-title":"Colocalization of Wnt\/beta-catenin and ACTH signaling pathways and paracrine regulation in aldosterone-producing adenoma","volume":"107","author":"De Sousa","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ando.2026.102520_bib1110","doi-asserted-by":"crossref","first-page":"E550","DOI":"10.1210\/jc.2014-3660","article-title":"Mast cell hyperplasia is associated with aldosterone hypersecretion in a subset of aldosterone-producing adenomas","volume":"100","author":"Duparc","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ando.2026.102520_bib1115","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1038\/s41467-020-16470-8","article-title":"The neuropeptide substance P regulates aldosterone secretion in human adrenals","volume":"11","author":"Wils","year":"2020","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.ando.2026.102520_bib1120","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1055\/a-1119-1063","article-title":"Role of mast cells in the control of aldosterone secretion","volume":"52","author":"Lopez","year":"2020","journal-title":"Horm Metab Res"},{"issue":"2","key":"10.1016\/j.ando.2026.102520_bib1125","doi-asserted-by":"crossref","first-page":"e045539","DOI":"10.1161\/JAHA.125.045539","article-title":"Regulation of aldosterone secretion by substance P and the neurokinin type 1 receptor in aldosterone- producing adenomas","volume":"15","author":"Lopez","year":"2026","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"10.1016\/j.ando.2026.102520_bib1130","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1210\/jcem.86.10.7917","article-title":"Production and metabolism of serotonin (5-HT) by the human adrenal cortex: paracrine stimulation of aldosterone secretion by 5-HT","volume":"86","author":"Lefebvre","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ando.2026.102520_bib1135","first-page":"1662","article-title":"Effect of the serotonin-4 receptor agonist zacopride on aldosterone secretion from the human adrenal cortex: in vivo and in vitro studies","volume":"77","author":"Lefebvre","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ando.2026.102520_bib1140","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1139\/y00-098","article-title":"Role of 5-HT in the regulation of the brain-pituitary-adrenal axis: effects of 5-HT on adrenocortical cells","volume":"78","author":"Contesse","year":"2000","journal-title":"Can J Physiol Pharmacol"},{"issue":"11","key":"10.1016\/j.ando.2026.102520_bib1145","doi-asserted-by":"crossref","first-page":"e4066","DOI":"10.1210\/clinem\/dgaa595","article-title":"Prevalence of somatic mutations in aldosterone-producing adenomas in Japanese patients","volume":"105","author":"Nanba","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ando.2026.102520_bib1150","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1210\/en.2013-1944","article-title":"Pharmacology and pathophysiology of mutated KCNJ5 found in adrenal aldosterone-producing adenomas","volume":"155","author":"Tauber","year":"2014","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.ando.2026.102520_bib1155","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1172\/JCI91733","article-title":"Macrolides selectively inhibit mutant KCNJ5 potassium channels that cause aldosterone-producing adenoma","volume":"127","author":"Scholl","year":"2017","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.ando.2026.102520_bib1160","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1161\/HYPERTENSIONAHA.117.10226","article-title":"Macrolides blunt aldosterone biosynthesis: a proof-of-concept study in KCNJ5 mutated adenoma cells ex vivo","volume":"70","author":"Caroccia","year":"2017","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.ando.2026.102520_bib1165","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1210\/er.2018-00139","article-title":"The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment","volume":"39","author":"Vaidya","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2026.102520_bib1170","doi-asserted-by":"crossref","first-page":"104276","DOI":"10.1016\/j.ebiom.2022.104276","article-title":"Machine learning for classification of hypertension subtypes using multi-omics: a multi-centre, retrospective, data- driven study","volume":"84","author":"Reel","year":"2022","journal-title":"EBioMedicine"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426626000417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426626000417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:42:39Z","timestamp":1780105359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426626000417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":117,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0003426626000417"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2026.102520","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic mechanisms of primary aldosteronism","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2026.102520","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102520"}}